CAR-T Therapy Development on the Rise

CAR-T Therapy Development on the Rise

LYNPARZA® (olaparib) Receives Positive EU CHMP Opinion For Use in Germline BRCA-Mutated HER2-Negative Advanced Breast Cancer

LYNPARZA® (olaparib) Receives Positive EU CHMP Opinion For Use in Germline BRCA-Mutated HER2-Negative Advanced Breast Cancer

The 2019 pipeline report: Changing the treatment paradigm

The 2019 pipeline report: Changing the treatment paradigm

Pfizer secures 4th cancer drug approval in 2 months

Pfizer secures 4th cancer drug approval in 2 months